Diabetes News and Research

Latest Diabetes News and Research

Weight-loss surgery minimizes use of medicines in people with obesity

Patients with obesity take significantly fewer medications after weight-loss surgery than their non-surgical counterparts, and end up spending 22.4 percent less on drugs for diabetes and heart disease after four years, according to new research.

6 Nov 2014

IU School of Medicine researchers identify new protein that can control diabetes

Indiana University School of Medicine researchers have identified a small protein with a big role in lowering plasma glucose and increasing insulin sensitivity.

6 Nov 2014

Researchers explore why many patients opt out of bariatric surgical procedure

Researchers from the University Health Network in Toronto are hoping to improve the operational efficiency of bariatric surgery programs to increase access to care. Studies have shown that bariatric operations can alleviate chronic health issues like diabetes and arthritis for extremely obese people.

6 Nov 2014

Medical illness common in bipolar disorder

Patients with bipolar disorder have high rates of medical illness, which often exceeds the levels observed in patients with unipolar depression, show results of a UK-based study.

5 Nov 2014

Study reveals outcomes of cosmetic surgery between older patients and younger ones

Senior citizens are at no higher risk for complications from cosmetic surgery than younger patients, according to a recent study by plastic surgeons at Vanderbilt University Medical Center.

5 Nov 2014

Light-activated diabetes drug: an interview with Dr David Hodson

We've known about chemicals that can be light-activated for about five to ten years now. They’ve mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.

5 Nov 2014

Modern bariatric surgery can cut medications in obesity patients

5 Nov 2014

Novo Nordisk announces re-launch of online patient support platform for people with diabetes

Novo Nordisk, a world leader in diabetes care, today announced the re-launch of Cornerstones4Care, an award-winning online patient support platform for people living with diabetes.

From Novo Nordisk 5 Nov 2014

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in bone and cartilage repair. Financial details were not disclosed.

5 Nov 2014

Type 2 diabetes and cardiovascular disease share common risk factors

Type 2 diabetes (T2D) and cardiovascular disease (CVD) appear to have a lot in common. They share risk factors such as obesity and they often occur together. If they also share the same genetic underpinings, then doctors could devise a way to treat them together too.

4 Nov 2014

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

New research shows that 140 million American adults - about 65 percent - are recommended for behavioral weight-loss treatment, with 83% of those (or 116 million) considered for pharmacotherapy.

4 Nov 2014

Major international health conference to be held next week in Singapore

The world is rapidly shrinking at the same time that medical collaborations are expanding - for the benefit of patient care right across the globe, a major international health conference in Singapore will hear next week.

4 Nov 2014

Texas A&M AgriLife Extension Service receives grant to help reduce chronic diseases

The Texas A&M AgriLife Extension Service has been awarded a "Programs to Reduce Obesity in High-Obesity Areas" grant to support national efforts by the U.S. Department of Health and Human Services to reduce chronic diseases, promote healthier lifestyles, reduce health disparities and control health care spending.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

Transition Therapeutics presents Phase 2 study of ELND005 drug for bipolar disorder

Transition Therapeutics Inc. ("Transition" or the "Company") today announced findings from a Phase 2 study of neuropsychiatric drug candidate, ELND005, as an adjunctive maintenance treatment for bipolar disorder type I patients (BPD).

4 Nov 2014

FDA approves Fluzone High-Dose vaccine sBLA to include efficacy data in Prescribing Information

Sanofi Pasteur, the vaccines division of Sanofi, today announced that the U.S. Food and Drug Administration has approved the supplemental biologics license application (sBLA) for Fluzone High-Dose (Influenza Vaccine) to include efficacy data in the Prescribing Information.

3 Nov 2014

Cogent OA teams up with Medpharm Publications to co-publish society-affiliated journals

Cogent OA is delighted to announce a partnership with Medpharm Publications of South Africa to co-publish several of its society-affiliated journals, providing leading online functionality and marketing services to further increase visibility and global reach.

3 Nov 2014

Davita Kidney Care joins fight against diabetes during National Diabetes Month

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, joins the fight against diabetes during National Diabetes Month this November by sharing suggestions and resources to help individuals manage the disease.

3 Nov 2014

Novo Nordisk introduces NovoRapid PumpCart insulin pump

Today, Novo Nordisk launches NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains NovoRapid (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes and their care staff.

From Novo Nordisk 3 Nov 2014

Mediterranean diet is good for your kidneys

New research indicates that adopting a Mediterranean-style diet can reduce the risk of developing chronic kidney disease by 50%.

31 Oct 2014

Diabetes News and Research

Latest Diabetes News and Research

Weight-loss surgery minimizes use of medicines in people with obesity

IU School of Medicine researchers identify new protein that can control diabetes

Researchers explore why many patients opt out of bariatric surgical procedure

Medical illness common in bipolar disorder

Study reveals outcomes of cosmetic surgery between older patients and younger ones

Light-activated diabetes drug: an interview with Dr David Hodson

Modern bariatric surgery can cut medications in obesity patients

Novo Nordisk announces re-launch of online patient support platform for people with diabetes

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

Type 2 diabetes and cardiovascular disease share common risk factors

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

Major international health conference to be held next week in Singapore

Texas A&M AgriLife Extension Service receives grant to help reduce chronic diseases

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Transition Therapeutics presents Phase 2 study of ELND005 drug for bipolar disorder

FDA approves Fluzone High-Dose vaccine sBLA to include efficacy data in Prescribing Information

Cogent OA teams up with Medpharm Publications to co-publish society-affiliated journals

Davita Kidney Care joins fight against diabetes during National Diabetes Month

Novo Nordisk introduces NovoRapid PumpCart insulin pump

Mediterranean diet is good for your kidneys

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in